Author :   Bortkevych O.P.

DYNAMICS OF DEVELOPMENT OF CHONDROITIN SULFATE AND THE PLACE OF GLYCOSAMINOGLYCAN-PEPTIDE COMPLEXES IN THE TREATMENT OF OSTEOARTHRITIS
Authors: Dubkova A.G. Krylova A.S. Bortkevych O.P. Tsymbaliuk T.S. №83 (1) 2021 / Review: 59
HISTORY OF STUDYING OF SYSTEMIC DISEASES CONNECTIVE TISSUE AND SYSTEMIC VASCULITIS IN THE MIRROR OF NUMISMATICS
Authors: Syniachenko O.V. Kovalenko V. Bortkevych O.P. Gnylorybov A.M.... №81 (3) 2020 / Review: 113
Comorbidity: definition, possible ways to diagnostics and treatment
Authors: Kovalenko V. Bortkevych O.P. №77 (3) 2019 / Review: 78
ANCA-associated Vasculitidies — updated approach to patient management
Authors: Bortkevych O.P. Korendovych V.V. Yarets’ka G.V. №68 (2) 2017 / Review: 22
Efficacy of PIASKLEDIN® 300 in patients with primary knee and hip osteoarthritis
Authors: Bortkevych O.P. Korendovych V.V. Biliavska Iu.V. №66 (4) 2016 / Review: 32
Updated treatment approaches in the managment rheumatic patients during pregnancy and lactation
Authors: Bortkevych O.P. Biliavska Iu.V. Korendovych V.V. №64 (2) 2016 / Review: 21
Substantiation report concerning retention of diagnosis «Juvenile rheumatoid arthritis» status in adult patients with a disease onset in childhood and adolescence
Authors: Kovalenko V. Shuba N.M. Yaremenko O.B. Оmelchenko L.I.... №63 (1) 2016 / Review: 25
Piascledin® 300 efficacy in the management of osteoarthritis: proved in clinical trials, confirmed by European practice
Author:Bortkevych O.P. №59 (1) 2015 / Review: 12
The use of hyaluronic acid for the treatment of osteoarthritis
Authors: Kovalenko V.M. Bortkevych O.P. Boichuk N.S. №59 (1) 2015 / Review: 14
New strategy of rheumatoid arthritis therapy (on the base of 2013 update recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs)
Authors: Kovalenko V.M. Bortkevych O.P. Biliavska Yu. №54 (4) 2013 / Review: 19
BiologiC Drugs: WHAT’S the difference?
Authors: Kovalenko V.M. Bortkevych O.P. Rekalov D.H. Medvedchuk G.Y. №52 (2) 2013 / Review: 14
ACHIEVEMENTS TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
Authors: Kovalenko V.M. Golovach I.Yu. Bortkevych O.P. №50 (4) 2012 / Review: 19
CURRENT OBJECTIVES FOR TARGET TREATMENT OF RHEUMATOID ARTHRITIS: FROM MONOCLONAL ANTIBODIES TO BLOCKERS OF SIGNALING PATHWAYS MOLECULES
Authors: Kovalenko V.M. Golovach I.Yu. Bortkevych O.P. №49 (3) 2012 / Review: 13
SMOKING AND DEVELOPMENT OF RHEUMATOIS ARTHRITIS: PATHOGENETIC PUZZLES COMPLETION
Authors: Kovalenko V.M. Golovach I.Yu. Bortkevych O.P. №48 (2) 2012 / Review: 15
INDIVIDUALIZATION OF RHEUMATOID ARTHRITIS TREATMENT: COURSE TO ACHIEVE OPTIMUM RESULTS
Authors: Kovalenko V.M. Bortkevych O.P. №45 (3) 2011 / Review: 14

123